Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic ...
To compare adverse event (AE) profiles between patients with prostate cancer receiving triplet therapy (docetaxel, androgen receptor signaling inhibitors [ARSIs], and androgen deprivation therapy [ADT]) and those receiving docetaxel-based therapy ( …